An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5 years (KLIMB).
Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelines
High airborne level of Aspergillus fumigatus and presence of azole-resistant TR34/L98H isolates in the home of a cystic fibrosis patient harbouring chronic colonisation with azole-resistant H285Y A. fumigatus.
Early glucose abnormalities are associated with pulmonary inflammation in young children with cystic fibrosis
Early glucose abnormalities are associated with pulmonary inflammation in young children with cystic fibrosis
Early glucose abnormalities are associated with pulmonary inflammation in young children with cystic fibrosis
